TCTC Holdings’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-80
Closed -$16.5K 549
2024
Q1
$17.2K Buy
+80
New +$16.8K ﹤0.01% 395
2023
Q2
Sell
-364
Closed -$69.7K 451
2023
Q1
$69.7K Hold
364
﹤0.01% 266
2022
Q4
$61.2K Sell
364
-183
-33% -$31.8K ﹤0.01% 261
2022
Q3
$97K Hold
547
﹤0.01% 217
2022
Q2
$112K Hold
547
﹤0.01% 214
2022
Q1
$130K Hold
547
0.01% 218
2021
Q4
$125K Hold
547
0.01% 244
2021
Q3
$106K Hold
547
﹤0.01% 244
2021
Q2
$116K Hold
547
0.01% 215
2021
Q1
$112K Buy
547
+364
+199% +$71.7K 0.01% 213
2020
Q4
$33K Buy
+183
New +$31.1K ﹤0.01% 278

Other funds holding CME

TCTC Holdings's CME Position: Q2 2024 in Review

TCTC Holdings sold out of CME Group (CME) in Q2 2024, closing a stake of 80 shares — an estimated $16.5K sold.

TCTC Holdings first reported a position in CME in Q4 2020 and held it in 11 quarters. The position peaked at $130K in Q1 2022. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • TCTC Holdings reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • TCTC Holdings sold 80 CME Group shares in Q2 2024, an estimated $16.5K.
  • TCTC Holdings first reported a position in CME Group in Q4 2020 and held it in 11 quarters.
  • TCTC Holdings's CME Group position peaked at $130K in Q1 2022.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on TCTC Holdings's 13F filing for Q2 2024, filed 6 Aug 2024.